Literature DB >> 24973145

Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administration.

ZhiQiang Zhou1, GuangFen Zhang, XiaoMin Li, XiaoYu Liu, Nan Wang, LiLi Qiu, WenXue Liu, ZhiYi Zuo, JianJun Yang.   

Abstract

Accumulating evidence has demonstrated that single subanesthetic dose of ketamine exerts rapid, robust, and lasting antidepressant-like effects. Nevertheless, repeated subanesthetic doses of ketamine produce psychosis-like effects with dysfunction of parvalbumin (PV) interneurons. We hypothesized that PV interneurons play an important role in the antidepressant-like actions of ketamine, and different changes in PV interneurons occur with the antidepressant-like and propsychotic-like effects of ketamine. To test this hypothesis, ketamine's antidepressant-like effects were evaluated by the forced swimming test. Ketamine-induced stereotyped behaviors and hyperactivity actions and the function of PV interneurons were also assessed. We demonstrated that an acute dose of 10 mg/kg ketamine induced significant antidepressant-like effects and reduced the levels of PV and the gamma-aminobutyric acid (GABA)-producing enzyme GAD67 in the rat prefrontal cortex. Moreover, inhibition of ketamine-induced loss of PV by apocynin blocked these antidepressant-like effects. Repeated administration of 30 mg/kg ketamine elicited stereotyped behaviors and hyperactivity actions as well as a longer duration of PV and GAD67 loss, higher brain glutamate levels, and lower brain GABA levels than acute single dose of ketamine. Our results reveal that the loss of phenotype of PV interneurons in the prefrontal cortex contributes to the antidepressant-like actions and is also involved in the propsychotic-like behaviors following acute and repeated ketamine administration, which may be partially mediated by the disinhibition of glutamate signaling. The different degrees and durations of the actions on PV interneurons produced by the two regimens of ketamine may partly underline the behavioral variance between the antidepressant- and propsychotic-like effects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24973145     DOI: 10.1007/s12035-014-8798-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  55 in total

1.  Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia.

Authors:  G Keilhoff; A Becker; G Grecksch; G Wolf; H-G Bernstein
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

Review 2.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

3.  NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

Review 4.  Signaling pathways underlying the rapid antidepressant actions of ketamine.

Authors:  Ronald S Duman; Nanxin Li; Rong-Jian Liu; Vanja Duric; George Aghajanian
Journal:  Neuropharmacology       Date:  2011-09-02       Impact factor: 5.250

5.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

Review 6.  The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.

Authors:  Lisa M Monteggia; Erinn Gideons; Ege T Kavalali
Journal:  Biol Psychiatry       Date:  2012-10-11       Impact factor: 13.382

7.  Rat cortical synaptosomes have more than one mechanism for Ca2+ entry linked to rapid glutamate release: studies using the Phoneutria nigriventer toxin PhTX2 and potassium depolarization.

Authors:  M A Romano-Silva; R Ribeiro-Santos; A M Ribeiro; M V Gomez; C R Diniz; M N Cordeiro; M J Brammer
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

8.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

9.  Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

Authors:  Sungho Maeng; Carlos A Zarate; Jing Du; Robert J Schloesser; Joseph McCammon; Guang Chen; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2007-07-23       Impact factor: 13.382

10.  Intravenous ketamine compared with diclofenac suppository in suppressing acute postoperative pain in women undergoing gynecologic laparoscopy.

Authors:  Maryam Vosoughin; Shabnam Mohammadi; Ali Dabbagh
Journal:  J Anesth       Date:  2012-05-11       Impact factor: 2.078

View more
  25 in total

1.  Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression.

Authors:  Wen-Xue Liu; Jing Wang; Ze-Min Xie; Ning Xu; Guang-Fen Zhang; Min Jia; Zhi-Qiang Zhou; Kenji Hashimoto; Jian-Jun Yang
Journal:  Psychopharmacology (Berl)       Date:  2015-10-29       Impact factor: 4.530

2.  Ketamine relieves depression-like behaviors induced by chronic postsurgical pain in rats through anti-inflammatory, anti-oxidant effects and regulating BDNF expression.

Authors:  Yitian Yang; Yuxiang Song; Xuan Zhang; Weixing Zhao; Tao Ma; Yi Liu; Penglei Ma; Yifan Zhao; Hong Zhang
Journal:  Psychopharmacology (Berl)       Date:  2020-03-03       Impact factor: 4.530

Review 3.  Recent insights into the mode of action of memantine and ketamine.

Authors:  Jon W Johnson; Nathan G Glasgow; Nadezhda V Povysheva
Journal:  Curr Opin Pharmacol       Date:  2014-12-02       Impact factor: 5.547

Review 4.  Mechanisms of ketamine and its metabolites as antidepressants.

Authors:  Evan M Hess; Lace M Riggs; Michael Michaelides; Todd D Gould
Journal:  Biochem Pharmacol       Date:  2021-12-27       Impact factor: 5.858

Review 5.  Parvalbumin interneuron alterations in stress-related mood disorders: A systematic review.

Authors:  George Perlman; Arnaud Tanti; Naguib Mechawar
Journal:  Neurobiol Stress       Date:  2021-08-12

6.  Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin.

Authors:  Stephanie Shiers; Grishma Pradhan; Juliet Mwirigi; Galo Mejia; Ayesha Ahmad; Sven Kroener; Theodore Price
Journal:  J Neurosci       Date:  2018-07-20       Impact factor: 6.167

7.  NOX2 Mediated-Parvalbumin Interneuron Loss Might Contribute to Anxiety-Like and Enhanced Fear Learning Behavior in a Rat Model of Post-Traumatic Stress Disorder.

Authors:  Fang-Fang Liu; Lin-Dong Yang; Xiao-Ru Sun; Hui Zhang; Wei Pan; Xing-Ming Wang; Jian-Jun Yang; Mu-Huo Ji; Hong-Mei Yuan
Journal:  Mol Neurobiol       Date:  2015-12-09       Impact factor: 5.590

8.  Repeated Neonatal Sevoflurane Exposure-Induced Developmental Delays of Parvalbumin Interneurons and Cognitive Impairments Are Reversed by Environmental Enrichment.

Authors:  Mu-Huo Ji; Zhong-Yun Wang; Xiao-Ru Sun; Hui Tang; Hui Zhang; Min Jia; Li-Li Qiu; Guang-Fen Zhang; Yong G Peng; Jian-Jun Yang
Journal:  Mol Neurobiol       Date:  2016-06-02       Impact factor: 5.590

Review 9.  Dementia-related psychosis and the potential role for pimavanserin.

Authors:  Jeffery L Cummings; D P Devanand; Stephen M Stahl
Journal:  CNS Spectr       Date:  2020-08-19       Impact factor: 3.790

10.  Electroacupuncture Ameliorates Chronic Inflammatory Pain-Related Anxiety by Activating PV Interneurons in the Anterior Cingulate Cortex.

Authors:  Fangbing Shao; Junfan Fang; Mengting Qiu; Sisi Wang; Danning Xi; Xiaomei Shao; Xiaofen He; Jianqiao Fang; Junying Du
Journal:  Front Neurosci       Date:  2021-07-05       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.